Showing results (1-10 of 26,446) with videos related to
Sort By:
Pageof 2,645
Journal of Pharmaceutical Sciences|July 24, 2025
Enhancing pharmacometric modeling with full Bayesian inference and Student's t-Based M3 Censoring: A simulated population PK study on robust handling of outliers and censored dataYiming Cheng, Yan LiJournal of Clinical Pharmacology|July 3, 2026
Decoupling CAR-T Expansion, Conversion, and Decay Timing: Physiologically Aligned Semi-Mechanistic Modeling With Smooth Gating and a Cauchy Likelihood Residual ModelYiming Cheng, Yan LiJournal of Pharmaceutical Sciences|May 28, 2026
Delay differential equation (DDE) modeling of CAR-T cellular kinetics: Application to BCMA-targeted (Ide-cel, Orva-cel) and CD19-targeted (Liso-cel) therapiesYiming Cheng, Yan LiJournal of Pharmacokinetics and Pharmacodynamics|June 17, 2026
Comparing heavy-tailed residual error models for outlier handling in population PK modelingYiming Cheng, Yan LiJournal of Clinical Pharmacology|May 29, 2026
Partial Differential Equation (PDE)-Based Spatial Pharmacometrics in NONMEM: Method of Lines (MOL) Implementation with AI-Assisted Model DevelopmentYiming Cheng, Yan LiCPT: Pharmacometrics & Systems Pharmacology|August 12, 2025
A Perspective on the Use of Poisson Versus Logistic Regression in Exposure-Response Analysis: Insights and ConsiderationsYiming Cheng, Ping Chen, Yan LiJournal of Pharmaceutical Sciences|July 27, 2025
Integrative population pharmacokinetic modeling of two BCMA-targeted and one CD19-targeted CAR-T therapies using full Bayesian inference with a student's t-based M3 censoring approach for robust handling of outliers and BLQ dataYiming Cheng, Hongxiang Hu, Ken Ogasawara, et al.Clinical Pharmacology : Advances and Applications|May 7, 2021
Population Pharmacokinetics of CC-122Yiming Cheng, Jian Chen, Michael Pourdehnad, et al.Journal of Clinical Pharmacy and Therapeutics|March 21, 2022
An open-label, phase 1, randomized, three treatments, three-period, crossover, relative bioavailability study of CC-292, a potent and orally available inhibitor of bruton tyrosine kinaseYiming Cheng, Liangang Liu, Yongjun Xue, et al.Journal of Pharmaceutical Sciences|February 13, 2024
Exploring Transformer Model in Longitudinal Pharmacokinetic/Pharmacodynamic Analyses and Comparing with Alternative Natural Language Processing ModelsYiming Cheng, Hongxiang Hu, Xin Dong, et al.Pageof 2,645